Jacky Luiten

Utility of diagnostic breast excision biopsies during two decades of screening mammography | 45 3 22. Rudin AV, Hoskin TL, Fahy A, et al. Flat epithelial atypia on core biopsy and upgrade to cancer: a systematic review and meta‐analysis. Ann Surg Oncol 2017;24(12):3549‐3558. 23. Sydnor MK, Wilson JD, Hijaz TA, et al. Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core‐needle biopsy. Radiology 2007;242(1):58‐62. 24. Margenthaler JA, Duke D, Monsees BS, et al. Correlation between core biopsy and excisional biopsy in breast high‐risk lesions. Am J Surg 2006;192(4):534‐537. 25. Mercado CL, Hamele‐Bena D, Oken SM, et al. Papillary lesions of the breast at percutaneous core‐ needle biopsy. Radiology 2006;238(3):801‐808. 26. Sen LQ, Berg WA, Hooley RJ, et al. Core breast biopsies showing lobular carcinoma in situ should Be excised and surveillance is reasonable for atypical lobular hyperplasia. AJR Am J Roentgenol 2016;207(5):1132‐1145. 27. Elshof LE, Tryfonidis K, Slaets L, et al. Feasibility of a prospective, randomised, open‐label, international multicentre, phase III, non‐inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ ‐ the LORD study. Eur J Cancer 2015;51(12):1497‐1510. 28. Francis A, Thomas J, Fallowfield L, et al. Addressing overtreatment of screendetected DCIS; the LORIS trial. Eur J Cancer 2015;51(16):2296‐303. 29. Reisch LM, Carney PA, Oster NV, et al. Medical malpractice concerns and defensive medicine: a nationwide survey of breast pathologists. Am J Clin Pathol 2015;144(6):916‐922. 30. Kern KA. The delayed diagnosis of breast cancer: medicolegal implications and risk prevention for surgeons. Breast Dis 2001;12:145‐158. 31. Smith‐Bindman R, Chu PW, Miglioretti DL, et al. Comparison of screening mammography in the United States and the United Kingdom. J Am Med Assoc 2003;290(16):2129‐2137.